insights_auto
Why is AKBA down 4,78%?
Dive Deeperchevron_right
AKBA:NASDAQ
Akebia Therapeutics Inc
US$0,47
arrow_downward
-4,78%(-0,024) 1D
13 ພ.ຈ., 16 ໂມງ 0 ນາທີ 01 ວິນາທີ GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for AKBA...
Open
US$0,49
High
US$0,57
Low
US$0,45
Mkt. cap
131,14 ລ້ານ
Avg. vol.
8,79 ລ້ານ
Volume
3,89 ລ້ານ
52-wk high
US$1,84
52-wk low
US$0,36
EPS
US$-0,16
Beta
0,24
Shares outstanding
277,66 ລ້ານ
No. of employees
194
Open
US$0,49
High
US$0,57
Low
US$0,45
Mkt. cap
131,14 ລ້ານ
Avg. vol.
8,79 ລ້ານ
Volume
3,89 ລ້ານ
52-wk high
US$1,84
52-wk low
US$0,36
EPS
US$-0,16
Beta
0,24
Shares outstanding
277,66 ລ້ານ
No. of employees
194
News stories
From web sources and news partners
Benzinga
·
1 ຊົ່ວໂມງກ່ອນ
VOO & Chill: Inflows Stay Strong as Risk-Off Sentiment Pressures the S&P 500
TradingView
·
2 ຊົ່ວໂມງກ່ອນ
SpaceX's S&P 500 bid gets new life as Elon Musk pitches Tesla merger
The Motley Fool
·
4 ຊົ່ວໂມງກ່ອນ
Warren Buffett's Berkshire Compounded at More Than 19% a Year Over Six Decades, Nearly Double the S&P 500's 10% Return. Can Investors Still Apply That Playbook Today?
Traders Union
·
2 ຊົ່ວໂມງກ່ອນ
Michael Kantro: Institutional investors focus on stock picking as S&P 500 targets have lost relevance
About Akebia Therapeutics Inc
CEO-
Employees194
Founded1 ມ.ກ. 2007
Headquartersແຄມບຣິກ, ມາຊາຊູເຊັດ, ສະຫະລັດ
SectorHealth Care
IndustryBiotechnology
Websiteakebia.com